Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in early diffuse cutaneous systemic sclerosis
2016-002651-25Phase 2Unknown
- Sponsor
- Research Governance and Integrity, University of Manchester
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in systemic sclerosis (SSc) comparing Prednisolone with Placebo (2 arms). Primary endpoints: Co-primary efficacy outcome measures and Renal safety. Status: unknown.
02
Drugs
prednisolone
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2016-002651-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002651-25.